Organigram Reports Second Quarter Fiscal 2022 Results

Organigram Reports Second Quarter Fiscal 2022 Results

Achieves positive Adjusted EBITDA two quarters earlier than expected driven by record high net revenue for the Company of $31.8 million and a top 3 national market share position among Canadian LPs.

HIGHLIGHTS

  • Achieved gross revenue of $43.9 million, up 128% from the same prior-year period and consistent with Q1 Fiscal 2022, despite the impact of seasonality
  • Continued record growth in net revenue, reaching $31.8 million, the highest in the history of the Company, up 117% from $14.6 million in the same prior-year period and 5% from $30.4 million in Q1 Fiscal 2022
  • Achieved positive Adjusted EBITDA of $1.6 million, two quarters ahead of the Company’s initial estimate
  • Reached 8.2% market share1 in February 2022, the #3 position among Canadian licensed producers for the second month in a row1
  • Maintained #1 position in dried flower, the largest category, which represents approximately half of the Canadian cannabis market1
  • Launched 18 new products, including extensions to the SHRED’ems gummies line and two new premium strains to the Edison brand, bringing the total number of core SKUs in market to 69
  • Shipped 1,692 kilograms of high margin flower to Israel and Australia, marking the highest quarterly International B2B shipments in the history of the Company
  • Acquired Quebec-based hash and craft cannabis producer Laurentian, an immediately accretive transaction providing the Company with a broadened product portfolio and increased footprint in Quebec 
  • Increased investment in Hyasynth, a pioneer in cannabinoid science. Once Hyasynth commences commercial production, the Company has the option to purchase Hyasynth’s proprietary biosynthesis-generated cannabinoids at a discount to the wholesale market price
  • Launched SHRED-X vapes, 510 vape cartridges with flavour profiles inspired by the unique flavours of the SHRED milled flower products
  • Received $6.3 million investment from BAT through the exercise of its rights pursuant to an Investor Rights Agreement with BAT, to enhance its equity ownership position in the Company from 18.8% to 19.4% as at the date hereof
  • Subsequent to quarter-end, leveraged the high visibility of the SHRED brand to introduce two new products. SHRED-X kief-infused blends, is a 50%/50% blend of kief and the popular SHRED milled flower – yet another innovative product that combines potency and flavour with convenience, and SHRED’ems POP!, gummies in the classic pop flavours of cola, root beer and cream soda

TORONTO–(BUSINESS WIRE)–
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2022 (“Q2 Fiscal 2022”).

“The culture of innovation and consumer focus we are building at Organigram has enabled us to not only create brands that are embraced by consumers, but continually innovate within those brands and across multiple product lines. We expect that leveraging these brands will allow us to continue to drive market share,” said Beena Goldenberg, Chief Executive Officer. “In addition to our continued success at building beloved brands, our ability to increase sales in international markets and capitalize on our accretive acquisitions, such as Laurentian and EIC, continue to contribute to our solid gains in market presence and sales growth.”

“We are also progressing well with the Laurentian integration. In less than three months we have been able to significantly increase distribution and begin to implement the synergies planned at acquisition. Automation to optimize production is also underway and expected to be complete by the end of Fiscal 2022,” added Goldenberg.

Select Key Financial Metrics (in $000s unless otherwise indicated)

Q2-2022

 

Q2-2021

 

% Change

Gross revenue

43,934

 

19,292

 

128 %

Excise taxes

(12,098)

 

(4,649)

 

160 %

Net revenue

31,836

 

14,643

 

117 %

Cost of sales

24,955

 

31,146

 

(20) %

Gross margin before fair value changes to biological assets & inventories sold

6,881

 

(16,503)

 

nm

Realized fair value on inventories sold and other inventory charges

(5,314)

 

(7,208)

 

nm

Unrealized gain (loss) on changes in fair value of biological assets

7,502

 

6,516

 

nm

Gross margin

9,069

 

(17,195)

 

nm

Adjusted gross margin1

8,255

 

(680)

 

nm

Adjusted gross margin %1

26 %

 

(5) %

 

nm

Selling (including marketing), general & administrative expenses2

13,998

 

10,329

 

36 %

Adjusted EBITDA1

1,556

 

(7,840)

 

nm

Net loss

(4,047)

 

(66,389)

 

nm

Net cash used in operating activities

(803)

 

(10,430)

 

nm

1 Adjusted gross margin, adjusted gross margin % and adjusted EBITDA are non-IFRS financial measures not defined by and do not have any standardized meaning under IFRS; please refer to the Company’s Q2 Fiscal 2022 MD&A for definitions and a reconciliation to IFRS.

2 Excluding non-cash share-based compensation.

nm – not meaningful

Select Balance Sheet Metrics (in $000s)

FEBRUARY

28, 2022

 

AUGUST

31, 2021

 

% Change

Cash & short-term investments

150,745

 

183,555

 

(18) %

Biological assets & inventories

56,187

 

48,818

 

15 %

Other current assets

29,627

 

28,242

 

5 %

Accounts payable & accrued liabilities

25,551

 

18,952

 

35 %

Current portion of long-term debt

80

 

80

 

— %

Working capital

189,597

 

234,349

 

(19) %

Property, plant & equipment

240,924

 

235,939

 

2 %

Long-term debt

192

 

230

 

(17) %

Total assets

585,102

 

554,017

 

6 %

Total liabilities

71,716

 

74,212

 

(3) %

Shareholders’ equity

513,386

 

479,805

 

7 %

“The additional revenue from Laurentian, and continued growth in recreational and B2B sales, combined with improving margins through improved operational efficiencies, allowed us to achieve positive Adjusted EBITDA two quarters earlier than originally projected,” stated Derrick West, Chief Financial Officer. “Our strong balance sheet and cash position as well as the completion of our facility expansion to meet market demand, positions us well to deliver sustained value to our shareholders.”

Key Financial Results for the Second Quarter Fiscal 2022

  • Net revenue:

    • Compared to the prior year, net revenue increased 117% to $31.8 million, from $14.6 million in Q2 Fiscal 2021. The increase was primarily due to an increase in adult-use recreational revenue and international revenue, partly offset by lower average net selling price (“ASP”) due to product mix and a decrease in medical revenue.
  • Cost of sales:

    • Q2 Fiscal 2022 cost of sales decreased by 20% to $25.0 million, from $31.1 million in Q2 Fiscal 2021. The decrease to cost of sales during a period when there was a large increase in sales was due to lower production costs, the elimination of unabsorbed overheads and significantly reduced inventory provisions.
  • Gross margin before fair value changes to biological assets, inventories sold, and other charges:

    • Q2 Fiscal 2022 margin improved to $6.9 million from negative $16.5 million in Q2 Fiscal 2021 largely due to higher net revenue and lower cost of sales as described above.
  • Gross margin:

    • Q2 Fiscal 2022 gross margin increased to a positive result from negative Q2 Fiscal 2021 gross margin largely due to higher Q2 Fiscal 2022 gross margin before fair value changes to biological assets and inventories sold as described above, as well as net non-cash negative fair value changes to biological assets and inventories sold in Q2 Fiscal 2022.
  • Adjusted gross margin2:

    • Q2 Fiscal 2022 adjusted gross margin was $8.3 million, or 26% of net revenue, compared to negative $0.7 million, or -5%, in Q2 Fiscal 2021. This was largely due to the higher overall sales volumes combined with lower cost of production.
  • Selling, general & administrative (SG&A) expenses:

    • Q2 Fiscal 2022 SG&A expenses increased to $14.0 million from $10.3 million in Q2 Fiscal 2021, primarily due to the higher spend to support the growth to the business combined with the acquisition of Laurentian.
  • Adjusted EBITDA3:

    • Q2 Fiscal 2022 adjusted EBITDA improved to positive $1.6 million compared to negative $7.8 million in Q2 Fiscal 2021, primarily due to the increase in adjusted gross margins, partially offset by the increase in SG&A expenses.
  • Net loss:

    • Q2 Fiscal 2022 net loss was $4.0 million, compared to a net loss of $66.4 million in Q2 Fiscal 2021, the reduction in the net loss is primarily due to the higher sales and gross margins in the current quarter.
  • Net cash used in operating activities:

    • Q2 Fiscal 2022 net cash used in operating activities was $5.3 million: this was primarily driven by the increase in inventories. In Q2 Fiscal 2021, net cash used in operating activities was $10.4 million, which was primarily driven by the loss from operations.

The following table reconciles the Company’s adjusted EBITDA.

Adjusted EBITDA Reconciliation (in $000s unless otherwise indicated)

 

Q2-2022

 

Q2-2021

Net loss as reported

 

$ (4,047)

 

$ (66,389)

Add/(Deduct):

 

 

 

 

Financing costs, net of investment income

 

(217)

 

669

Income tax recovery

 

(97)

 

Depreciation, amortization, and gain (loss) on disposal of property, plant and equipment (per statement of cash flows)

 

11,024

 

5,222

Impairment of intangible assets

 

 

Impairment of property, plant and equipment

 

2,000

 

Share of loss and impairment loss from loan receivable and investments in associates

 

499

 

844

Unrealized (gain) loss on changes in fair value of contingent consideration

 

666

 

154

Realized fair value on inventories sold and other inventory charges

 

5,314

 

7,208

Unrealized gain (loss) on change in fair value of biological assets

 

(7,502)

 

(6,516)

Share-based compensation (per statement of cash flows)

 

877

 

1,167

COVID-19 related charges, net of government subsidies

 

 

(2,709)

Legal provisions

 

 

500

Share issuance costs allocated to derivative warrant liabilities and change in fair value of derivative liabilities

 

(10,633)

 

37,659

Incremental fair value component of inventories sold from acquisitions

 

663

 

Acquisition transaction costs

 

1,148

 

Provisions and impairment of inventories and biological assets and provisions of inventory to net realizable value

 

711

 

13,549

Research and development expenditures

 

1,150

 

802

Adjusted EBITDA

 

$ 1,556

 

$ (7,840)

The following table reconciles the Company’s adjusted gross margin:

Adjusted Gross Margin Reconciliation (in $000s unless otherwise indicated)

Q2-2022

 

Q2-2021

Net revenue

$ 31,836

 

$ 14,643

Cost of sales before adjustments

23,581

 

15,323

Adjusted Gross margin

8,255

 

(680)

Adjusted Gross margin %

26 %

 

(5) %

Less:

 

 

 

Provisions (recoveries) and impairment of inventories and biological assets

686

 

10,050

Provisions to net realizable value

25

 

3,499

Incremental fair value component on inventories sold from acquisitions

663

 

Unabsorbed overhead

 

2,274

Gross margin before fair value adjustments

6,881

 

(16,503)

Gross margin % (before fair value adjustments)

22 %

 

(113) %

Add/(Deduct):

Realized fair value on inventories sold and other inventory charges

(5,314)

 

(7,208)

Unrealized gain on changes in fair value of biological assets

7,502

 

6,516

Gross margin(1)

9,069

 

(17,195)

Gross margin %(1)

28 %

 

(117) %

Canadian Recreational Market

SHRED X 510 vape cartridges

  • In February 2022, the Company launched SHRED X vape cartridges in the 510 format. This new line of vapes is offered in flavours of the popular milled flower product: Tropic Thunder, Megamelon and Gnarberry, and are blended with a unique terpene blend to create a true cannabis flavour.

SHRED X kief-infused blends

  • Building on its leadership position with SHRED, the best selling milled flower product, the Company in March introduced a new innovative product consisting of a 50%/50% blend of SHRED combined with high quality kief. SHRED-X combines the convenience of milled flower with the higher potency of kief.

Edison new strains

  • The Company solidified the premium positioning of Edison, its flagship brand, by introducing two new strains of premium flower to its lineup. This includes Edison Kush Cakes, an indica-dominant cultivar with a high potency of 22-28% THC, and Edison Frozen Lemons, a sativa-dominant strain with a lemon flavour and aroma, and a potency of 20-26% THC.

SHRED’ems line extensions

  • SHRED’ems gummies, launched in August 2021, leveraged the popularity of the Company’s SHRED milled flower products, and quickly grew to a #3 position4 in the gummies category. Building on the success of the initial launch, the Company launched five new flavours, bringing a total of eight SHRED’ems SKUs to the market.

Big Bag O’ Buds line extension

  • To further differentiate its offering in the value segment, the Company introduced Pink Cookies to its Big Bag ‘O Buds product line. Pink Cookies is an indica-dominant strain with a potency of 18-24% THC. The Company now has five core Big Bag ‘O Buds SKUs available in the market, reflecting increasing consumer demand for variety in the value segment.

Research and Product Development

Product Development Collaboration (“PDC”) and Centre of Excellence (“CoE”)

  • In Fiscal 2021, Organigram launched the PDC with BAT which was established to focus on research and product development activities for the next generation of cannabis products, with an initial focus on CBD. R&D efforts are progressing well and the Company will be applying these discoveries and deep scientific knowledge to both strengthen its existing in market products, as well as the development of novel and new consumer-centric innovations.

Plant Science, Breeding and Genomics R&D in Moncton

  • Organigram’s cultivation program is a key strategic advantage for the Company and focuses on cultivating a pipeline of unique and sought-after genetics, maximizing flower quality in terms of THC yield, terpene profiles and general plant health to meet evolving consumer demand. The Company is aggressively expanding its in-house breeding program, and will be launching the first of many in-house genetic in the coming months.

Strategic Investment in Hyasynth Biologicals Inc. (“Hyasynth”)

  • Following the most recent investment of $2.5 million in December 2021, Organigram has invested a total of $10 million in Hyasynth through the participation in three tranches of convertible debentures. The Company has appointed two nominees to Hyasynth’s Board of Directors and has the option to purchase Hyasynth produced cannabinoids at a discount to the wholesale market price for a period of ten years from the date of Hyasynth’s commencement of commercial production.

International

  • In Q2 Fiscal 2022, the Company made two international shipments. In February, the Company shipped 1,692 kilograms of dry flower to Israel under its agreement with Canndoc and to Australia through Cannatrek.
  • Recent political changes and cannabis election ballot initiatives for medical and recreational use in the United States suggest that the potential movements to U.S. federal legalization of cannabis (THC) have increased momentum, but the timing and outcome remain difficult to predict. Organigram continues to monitor and develop a potential U.S. THC strategy and evaluate CBD entry opportunities in the United States.

Liquidity and Capital Resources

  • On February 28, 2022, the Company had unrestricted cash and short-term investments balance of $151 million compared to $184 million at August 31, 2021.
  • Organigram believes its capital position is healthy and that there is sufficient liquidity available for the near to medium term.

Capital Structure

in $000s

FEBRUARY

28, 2022

 

AUGUST

31, 2021

Current and long-term debt

272

 

310

Shareholders’ equity

513,386

 

479,805

Total debt and shareholders’ equity

513,658

 

480,115

in 000s

 

 

 

Outstanding common shares

313,690

 

298,786

Options

7,783

 

7,797

Warrants

16,944

 

16,944

Top-up rights

6,382

 

6,559

Restricted share units

1,352

 

1,186

Performance share units

269

 

472

Total fully-diluted shares

346,420

 

331,744

Outstanding basic and fully diluted share count as at April 11, 2022 is as follows:

in 000s

 

APRIL 11, 2022

Outstanding common shares

 

313,690

Options

 

7,764

Warrants

 

16,944

Top-up rights

 

6,541

Restricted share units

 

1,352

Performance share units

 

269

Total fully-diluted shares

 

346,560

Outlook5

Net revenue

  • Organigram currently expects Q3 Fiscal 2022 revenue to be higher than Q2 Fiscal 2022. This expectation is largely due to ongoing sales momentum, stronger forecasted market growth, the Company’s expanded product line in multiple segments, greater capacity to meet demand at the Moncton Campus, increased throughput at the Winnipeg facility and the Laurentian acquisition.
  • Net revenue growth is expected from the Company’s products as evidenced by Organigram’s growing national adult-use recreational retail market share (“market share”) from 7.6% in Q1 of September 2021 to 8.4% in March 20226.
  • In addition, the continuation of shipments to Canndoc in Israel and Cannatrek in Australia is expected to generate higher sequential revenue in Fiscal 2022 as compared to Fiscal 2021. The Company believes it is better equipped to fulfill demand in Fiscal 2022 with larger harvests expected compared to Fiscal 2021. Revenues in Fiscal 2022 to date included two shipments to Canndoc that totaled approximately $7.0 million, and one shipment to Cannatrek for approximately $1.0 million. Orders received from other international customers support the Company’s expectation of continued revenue growth from Fiscal 2021 to Fiscal 2022.
  • Organigram expects to be positioned to generate further revenue growth from the production of soft chews/gummies and other edible products.
  • The Company also expects to realize additional revenue through the recent acquisition of Laurentian and will make growth-focused capital expenditures at Laurentian which have the potential to further increase EBITDA generation. Since the acquisition, the Company has accelerated the distribution and sale of Tremblant Cannabis, its flagship hash brand in Ontario, increasing distribution from 25% to 40% of retail stores and growing quarterly sales by 21% compared to Laurentian’s sales in the three months ended November 30, 2022. By leveraging Organigram’s industry-leading national distribution and field sales network, Laurentian products will be available in all Canadian provinces in Fiscal 2022.

Adjusted gross margins

  • The Company expects to see a sequential improvement in adjusted gross margins in Q3 Fiscal 2022 and has put measures in place that it expects will further improve margins over time.
  • The overall level of Q3 Fiscal 2022 adjusted gross margins versus Q2 Fiscal 2022 will also be dependent on other factors, including product category and brand sales mix.
  • Organigram has identified the following opportunities which it believes have the potential to further improve adjusted gross margins over time:

    • Economies of scale and efficiencies gained as it continues to scale up cultivation, including the grow rooms that will be available after completing the construction of Phase 4C of the Moncton Campus;
    • Changes to its growing and harvesting methodologies, design improvements and environmental enhancements which should improve operating conditions of the Moncton Campus, resulting in higher-quality flower and improved yields;
    • Continued investment in automation which will drive cost efficiencies and reduce dependence on manual labor;
    • Continued investment in the Edison brand, including product innovations across multiple categories and increased investment in building brand equity within the premium segment, both geared toward securing higher margins;
    • Additional innovative product launches such as Edison Jolts, SHRED’ems, Monjour and most recently SHRED X kief-infused blends, which represent new potential avenues for growth with expected attractive long-term margin profiles for the Company; and
    • Margin contribution from the addition of the Laurentian portfolio of products.

Second Quarter Fiscal 2022 Conference Call

The Company will host a conference call to discuss its results with details as follows:

Date: April 12, 2022

Time: 8:00am Eastern Time

To register for the conference call, please use this link:

https://conferencingportals.com/event/RUyBPhzX

To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.

To access the webcast:

https://events.q4inc.com/attendee/457187993

A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.

Non-IFRS Financial Measures

This news release refers to certain financial performance measures (including adjusted gross margin and adjusted EBITDA) that are not defined by and do not have a standardized meaning under International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. Non-IFRS financial measures are used by management to assess the financial and operational performance of the Company. The Company believes that these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company’s operating results, underlying performance and prospects in a similar manner to the Company’s management. As there are no standardized methods of calculating these non-IFRS measures, the Company’s approaches may differ from those used by others, and accordingly, the use of these measures may not be directly comparable. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Please refer to the Company’s Q2 Fiscal 2022 MD&A for definitions and, in the case of adjusted EBITDA, a reconciliation to IFRS amounts.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc. licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Québec, with a dedicated manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

This news release contains forward-looking information. Forward-looking information, in general, can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “could”, “would”, “might”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “continue”, “budget”, “schedule” or “forecast” or similar expressions suggesting future outcomes or events. They include, but are not limited to, statements with respect to expectations, projections or other characterizations of future events or circumstances, and the Company’s objectives, goals, strategies, beliefs, intentions, plans, estimates, forecasts, projections and outlook, including statements relating to the Company’s future performance, the Company’s positioning to capture additional market share and sales, expectations for consumer demand, expected increase in SKUs, expected improvement to gross margins before fair value changes to biological assets and inventories, expectations regarding gross margins in Fiscal 2022, the Company’s plans and objectives including around the CoE, availability and sources of any future financing, expectations regarding the impact of COVID-19, availability of cost efficiency opportunities, the increase in the number of retail stores, the ability of the Company to fulfill demand for its revitalized product portfolio with increased staffing, expectations relating to greater capacity to meet demand due to increased capacity at the Company’s facilities, expectations around lower product cultivation costs, the ability to achieve economies of scale and ramp up cultivation, expectations pertaining to the increase of automation and reduction in reliance on manual labour, expectations around the launch of higher margin dried flower strains, expectations around market and consumer demand and other patterns related to existing, new and planned product forms including by EIC and Laurentian; timing for launch of new product forms, ability of those new product forms to capture sales and market share, estimates around incremental sales and more generally estimates or predictions of actions of customers, suppliers, partners, distributors, competitors or regulatory authorities; continuation of shipments to Canndoc Ltd. and Cannatrek Ltd.; statements regarding the future of the Canadian and international cannabis markets and, statements regarding the Company’s future economic performance. These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control. Forward-looking information has been based on the Company’s current expectations about future events.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors – including the heightened uncertainty as a result of COVID-19 including any continued impact on production or operations, impact on demand for products, effect on third party suppliers, service providers or lenders; general economic factors; receipt of regulatory approvals or consents and any conditions imposed upon same and the timing thereof, ability to meet regulatory criteria which may be subject to change, change in regulation including restrictions on sale of new product forms, changing listing practices, ability to manage costs, timing and conditions to receiving any required testing results and certifications, results of final testing of new products, timing of new retail store openings being inconsistent with preliminary expectations, changes in governmental plans including related to methods of distribution and timing and launch of retail stores, timing and nature of sales and product returns, customer buying patterns and consumer preferences not being as predicted given this is a new and emerging market, material weaknesses identified in the Company’s internal controls over financial reporting, the completion of regulatory processes and registrations including for new products and forms, market demand and acceptance of new products and forms, unforeseen construction or delivery delays including of equipment and commissioning, increases to expected costs, competitive and industry conditions, customer buying patterns and crop yields – that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time under the Company’s issuer profile on the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and reports and other information filed with or furnished to the United States Securities and Exchange Commission (“SEC”) from time to time on the SEC’s Electronic Document Gathering and Retrieval System (“EDGAR”) at www.sec.gov, including the Company’s most recent MD&A and AIF. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward looking information is subject to risks and uncertainties that are addressed in the “Risk Factors” section of the MD&A dated April 11, 2022 and there can be no assurance whatsoever that these events will occur.

____________________________

1 Hifyre data extract from March 25, 2022

2 Adjusted gross margin is a non-IFRS financial measure not defined by and does not have any standardized meaning under IFRS; please refer to the Company’s Q2 2022 MD&A for definitions and a reconciliation to IFRS.

3 Adjusted EBITDA is a non-IFRS financial measure not defined by and does not have any standardized meaning under IFRS; please refer to the Company’s Q2 2022 MD&A for definitions and a reconciliation to IFRS.

4 Hifyre data extract from March 25, 2022

5 The disclosure in this section are subject to the risk factors referenced in the “Risk Factors” section of the Company’s Q2 Fiscal 2022 MD&A, which is available in the Company’s profile at www.sedar.com. Without limiting the generality of the foregoing, the expectations concerning revenue, adjusted gross margins and SG&A are based on the following general assumptions: consistency of revenue experience with indications of second quarter performance to date, consistency of ordering and return patterns or other factors with prior periods and no material change in legal regulation, market factors or general economic conditions. The Company disclaims any obligation to update any of the forward-looking information except as required by applicable law. See cautionary statement in the “Introduction” section at the beginning of the Company’s Q2 Fiscal 2022 MD&A.

6 Hiyre data extract from April 4, 2022

For Investor Relations enquiries, please contact:

[email protected]

For Media enquiries, please contact:

Megan McCrae, Senior Vice President, Marketing and Communications [email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Alternative Medicine Retail Health Agriculture Natural Resources Specialty Food/Beverage

MEDIA:

Logo
Logo

VIZIO Presents Exclusive Discounts and Promotions for Consumers from Popular Streaming Services

VIZIO Presents Exclusive Discounts and Promotions for Consumers from Popular Streaming Services

Apple TV+, discovery+, and fuboTV offers available to VIZIO users

IRVINE, Calif.–(BUSINESS WIRE)–
VIZIO (NYSE: VZIO) today announced its latest promotions and exclusive subscription discounts as part of an ongoing initiative to deliver even more value to VIZIO Smart TV owners.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220412005410/en/

Apple TV+, discovery+, and fuboTV offers available to VIZIO users (Photo: Business Wire)

Apple TV+, discovery+, and fuboTV offers available to VIZIO users (Photo: Business Wire)

These promotions give consumers just one more reason to buy a VIZIO Smart TV with “out of the box” entertainment, immediate access to fan-favorite TV shows, movies, and some of the best deals available from participating streaming services including Apple TV+, discovery+ and fuboTV. Check out the following promotions kicking off in April:

Apple TV+ — 3-Month Promotional Trial

New Apple TV+ subscribers can take advantage of a 3-month promotional trial for all new and existing VIZIO Smart TV owners. The offer will be presented on the VIZIO home screen through promotional banners with the opportunity to start redemption right from the home screen. Subscribers can enjoy award-winning Apple Originals such as “Ted Lasso,” newly premiered series including “WeCrashed,” and the upcoming documentary event series “They Call Me Magic” (premiering April 22), as well as the Academy Award-winning Apple Original Film “CODA.” This offer is available between April 25 – May 30, 2022.

discovery+ — 30-day Promotional Trial

New discovery+ subscribers will get access to an exclusive 30-day promotional trial following the purchase and registration of a new VIZIO TV. New users gain access to more than 60,000 episodes of current and classic shows from Discovery’s iconic portfolio of networks, including HGTV, Food Network, TLC, ID, OWN, Travel Channel, Discovery Channel, Animal Planet and Magnolia Network, as well as more than 200 discovery+ original titles and hundreds of hours of exclusive content like Shark Week. The promo offer will be shared to the new owner’s email address with a link to redeem the trial. The offer is available between April 22 – October 22, 2022.

fuboTV — 20% Off First Month

New fuboTV subscribers can get 20% off the first month of their subscription until April 15th. VIZIO smart TV owners can access the offer through the VIZIO home screen and quickly enjoy fubo’s cable TV replacement product. With fuboTV, subscribers can stream a broad mix of 100+ live sports, news and entertainment networks including every Nielsen-rated sports channel (source: Nielsen Total Viewers, 2021). Simply look for the promotional banners and sign up in a few clicks.

VIZIO continues to enhance the customer experience with new features and content, giving users endless entertainment options.

“VIZIO’s mission is to bring the best possible entertainment experience to the millions of people that use our products every day. Working with our content partners to extend discounts on their subscription services so that VIZIO audiences can access premium programming helps us deliver on that mission,” said Liz Buhn, Senior Director of Partner Marketing at VIZIO.

About VIZIO

Founded and headquartered in Orange County, California, our mission at VIZIO Holding Corp. (NYSE: VZIO) is to deliver immersive entertainment and compelling lifestyle enhancements that make our products the center of the connected home. We are driving the future of televisions through our integrated platform of cutting-edge Smart TVs and powerful operating system. We also offer a portfolio of innovative sound bars that deliver consumers an elevated audio experience. Our platform gives content providers more ways to distribute their content and advertisers more tools to connect with the right audience.

For more information, visit VIZIO.com and follow VIZIO on Facebook, Twitter, and Instagram.

Press Contact for VIZIO:

Jodie McAfee

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Retail Audio/Video Entertainment Online Consumer Marketing Software Advertising Other Consumer Communications Internet Hardware Consumer Electronics

MEDIA:

Logo
Logo
Photo
Photo
Apple TV+, discovery+, and fuboTV offers available to VIZIO users (Photo: Business Wire)

Littelfuse Acquires Embed

Littelfuse Acquires Embed

Embedded software and firmware expands technical capabilities

CHICAGO–(BUSINESS WIRE)–Littelfuse, Inc. (NASDAQ: LFUS), an industrial technology manufacturing company empowering a sustainable, connected, and safer world, today announced it has acquired Embed, Ltd. Founded in 2005, Embed is a proven provider of embedded software and firmware developed for a broad range of applications serving transportation end markets. Embed is headquartered in Coventry, United Kingdom.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220412005373/en/

“We are excited to welcome the Embed team to Littelfuse,” said Matt Cole, Littelfuse Senior Vice President, eMobility and Corporate Strategy. “The addition of Embed will help us better serve our customers by expanding our software engineering expertise and technical capabilities. With the increasing complexity of electronification within transportation applications, the inclusion of Embed will help Littelfuse respond quickly to the evolving needs of our customers.”

Littelfuse will share additional details about Embed during the company’s first quarter of fiscal 2022 earnings conference call.

About Littelfuse

Littelfuse (NASDAQ: LFUS) is an industrial technology manufacturing company empowering a sustainable, connected, and safer world. Across more than 15 countries, and with approximately 17,000 global associates, we partner with customers to design and deliver innovative, reliable solutions. Serving over 100,000 end customers, our products are found in a variety of industrial, transportation and electronics end markets – everywhere, every day. Learn more at Littelfuse.com.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995

The statements in this press release that are not historical facts are intended to constitute “forward-looking statements” entitled to the safe-harbor provisions of the Private Securities Litigation Reform Act. Such statements are based on Littelfuse’s current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties, include, but are not limited to, risks and uncertainties relating to general economic conditions; the severity and duration of the COVID-19 pandemic and the measures taken in response thereto and the effects of those items on the company’s business; product demand and market acceptance; the impact of competitive products and pricing; product quality problems or product recalls; capacity and supply difficulties or constraints; coal mining exposures reserves; cybersecurity matters; failure of an indemnification for environmental liability; exchange rate fluctuations; commodity and other raw material price fluctuations; the effect of Littelfuse, Inc.’s (“Littelfuse” or the “Company”) accounting policies; labor disputes; restructuring costs in excess of expectations; pension plan asset returns less than assumed; integration of acquisitions; uncertainties related to political or regulatory changes; and other risks which may be detailed in the company’s Securities and Exchange Commission filings. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, actual results and outcomes may differ materially from those indicated or implied in the forward-looking statements. This release should be read in conjunction with information provided in the financial statements appearing in the company’s Annual Report on Form 10-K for the year ended January 1, 2022. Further discussion of the risk factors of the company can be found under the caption “Risk Factors” in the company’s Annual Report on Form 10-K for the year ended January 1, 2022, and in other filings and submissions with the SEC, each of which are available free of charge on the company’s investor relations website at investor.littelfuse.com and on the SEC’s website at sec.gov. These forward-looking statements are made as of the date hereof. The company does not undertake any obligation to update, amend or clarify these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the availability of new information.

LFUS-A

Littelfuse, Inc.

Investor Contact:

Trisha Tuntland

Head of Investor Relations

(773) 628-2163

Media Contact:

Steve Schrier

Head of Corporate Communications

(773) 628-2112

[email protected]

KEYWORDS: Europe United States United Kingdom North America Illinois

INDUSTRY KEYWORDS: Other Manufacturing Other Transport Technology Semiconductor Engineering Transport Automotive Manufacturing Software Manufacturing Hardware

MEDIA:

Logo
Logo
Logo
Logo

Burger King, the National Fish and Wildlife Foundation and Cargill Join Together toHelp Conserve and Restore Grasslands and Wildlife Species Through Regenerative Agriculture Practices in the Southern Great Plains

Burger King, the National Fish and Wildlife Foundation and Cargill Join Together toHelp Conserve and Restore Grasslands and Wildlife Species Through Regenerative Agriculture Practices in the Southern Great Plains

Up to $5M in funding will be provided through the partnership which has the potential to sequester up to 360,000 metric tons of carbon per year — enough carbon to offset the energy needed to power 43,000 U.S. homes for one year

MIAMI–(BUSINESS WIRE)–
Today, Burger King and Cargill announce a partnership with the National Fish and Wildlife Foundation (NFWF), the largest private conservation grant provider in the U.S., to support cattle ranchers committed to addressing climate change through regenerative agriculture practices in Colorado, Kansas, Nebraska, New Mexico, Oklahoma and Texas. This five-year initiative with up to $5 million in funding, brings together two major beef brands dedicated to emissions reduction, reinforcing the important role beef and cattle play in helping the Great Plains thrive. The funding is expected to generate 1:1 matching contributions from NFWF, creating a total on-the-ground impact of up to $10 million.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220411005905/en/

Burger King, the National Fish and Wildlife Foundation and Cargill Join Together to Help Conserve and Restore Grasslands and Wildlife Species Through Regenerative Agriculture Practices in the Southern Great Plains (Photo: Business Wire)

Burger King, the National Fish and Wildlife Foundation and Cargill Join Together to Help Conserve and Restore Grasslands and Wildlife Species Through Regenerative Agriculture Practices in the Southern Great Plains (Photo: Business Wire)

Through this partnership, Burger King, Cargill and NFWF will bring financial and technical resources to ranching organizations in the Southern Great Plains to improve grassland management and reduce greenhouse gas emissions. The Southern Great Plains host a unique set of wildlife species that are specifically adapted to this grassland ecosystem, and many of these species are year-round residents that live on or migrate through ranching lands.

Today, NFWF awarded three grants made possible by Burger King and Cargill funding to ranchers in Kansas, New Mexico and Texas to support their efforts to plan and implement voluntary grassland management practices with consideration to the unique needs of their land.

“We, along with our research partner Working Lands Conservation, are thrilled by this amazing opportunity to support livestock producers in stewarding the Southern Great Plains,” said Lesli Allison, Western Landowners Alliance executive director. “This project highlights the key role that ranchers and grazing animals play in maintaining grassland ecosystems, feeding our nation and sustaining the economic vitality of rural communities.” Rancher and project partner Bret Riley added, “Building good prairie chicken habitat builds good cow habitat. These are win-win management strategies that we are proud to work with agency and conservation partners on.”

With support from Burger King and Cargill, the sustainable grazing practices implemented by ranchers over the next five years will have far-reaching impact with the potential to sequester up to 360,000 metric tons of carbon dioxide equivalent (CO₂e) per year, the equivalent of removing 904 million miles driven or the energy to power 43,000 U.S. homes for one year.1

“As one of the biggest buyers of beef in North America, partnering with Cargill and NFWF allows us to accelerate ambitious efforts to reduce greenhouse gas emissions in our beef supply chain and to make meaningful impacts important to our planet and Guests,” said Tom Curtis, President of Burger King. “Put simply — it’s the right thing for us to do. Beef can be a force for good, particularly when it comes to improved rangeland management as a mechanism for directly addressingclimate change. We’re committed to creating a more resilient food system and collaborating as a team to advance noticeable change.”

“The implementation of voluntary conservation measures supported by the Southern Plains Grassland Program will focus on scaling grazing practices that conserve and restore grasslands and wildlife species through innovative and localized approaches,” said Jeff Trandahl, executive director and CEO of NFWF. “These projects will make grasslands more resilient to changing conditions, and we look forward to expanding this work by connecting conservation experts with ranchers interested in making a real change. By creating a community-based conservation plan, we’ll see meaningful benefits for both the environment and participating ranchers.”

Heather Tansey, Cargill Vice President, Environmental Sustainability added, “It will take a multi-pronged approach to protect, regenerate and restore lands to mitigate climate impacts. As part of Cargill’s largest and most ambitious program on climate change, BeefUp Sustainability, we recognize that our farmers and ranchers across North America are already leading environmental stewardship practices and just need further incentives, tools and training to help scale these impactful practices.”

Cross-industry collaboration creates an opportunity for beef production to preserve and positively impact land and resources. Burger King, Cargill and NFWF are each committed to making beef production more sustainable and have already implemented similar sustainable agriculture programs across North America to optimize beef production that is healthy for customers, regenerative for land and profitable for farmers.

This Southern Great Plains initiative exemplifies the actions Burger King parent company Restaurant Brands International is taking to meet its Science Based Targets initiative approved goal to reduce Scope 3 emissions intensity by 50% per metric ton of food, as well as support achieving its overall goal of being net-zero emissions by 2050, compared to a 2019 baseline. Through projects like this and other actions, Restaurant Brands International expects to prevent an estimated 25.4 million metric tons of carbon dioxide equivalent (CO₂e) from being released into the atmosphere by 2030, as compared to a business as usual scenario. This is the equivalent of taking 5.5. million passenger cars off the road for an entire year.2

For more information, visit https://www.nfwf.org/programs/southern-plains-grassland-program.

About BURGER KING®

Founded in 1954, the Burger King® brand is a global fast-food hamburger chain known for food quality and value as the only place guests can get the iconic flame-grilled Whopper® sandwich. The Burger King system operates more than 18,700 locations in more than 100 countries and U.S. territories. Almost 100 percent of Burger King restaurants are owned and operated by independent franchisees, many of them family-owned operations that have been in business for decades. To learn more about the Burger King brand, please visit the Burger King brand website at www.bk.com or follow us on Facebook, Twitter, Instagram and TikTok.

About the National Fish and Wildlife Foundation

Chartered by Congress in 1984, the National Fish and Wildlife Foundation (NFWF) protects and restores the nation’s fish, wildlife, plants and habitats. Working with federal, corporate and individual partners, NFWF has funded more than 6,000 organizations and generated a total conservation impact of $7.4 billion. Learn more at www.nfwf.org.

About Cargill

Cargill’s 155,000 employees across 70 countries work relentlessly to achieve our purpose of nourishing the world in a safe, responsible, and sustainable way. Every day, we connect farmers with markets, customers with ingredients, and people and animals with the food they need to thrive.

We combine 156 years of experience with new technologies and insights to serve as a trusted partner for food, agriculture, financial and industrial customers in more than 125 countries. Side-by-side, we are building a stronger, sustainable future for agriculture. For more information, visit Cargill.com and our News Center.

1www.epa.gov/energy/greenhouse-gas-equivalencies-calculator

1https://www.rbi.com/English/news/news-details/2021/Restaurant-Brands-International-Sets-Science-Based-Targets-to-Reduce-Greenhouse-Gas-Emissions-50-by-2030-and-Plans-to-Reach-Net-Zero-by-2050/default.aspx

2 According to calculations based on 2021 data from the U.S. EPA and the latest available U.S. census data

Brooke Mogan

[email protected]

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Retail Restaurant/Bar Other Philanthropy Philanthropy

MEDIA:

Photo
Photo
Burger King, the National Fish and Wildlife Foundation and Cargill Join Together to Help Conserve and Restore Grasslands and Wildlife Species Through Regenerative Agriculture Practices in the Southern Great Plains (Photo: Business Wire)
Logo
Logo

Babylon Announces First Quarter 2022 Financial Results Conference Call

Babylon Announces First Quarter 2022 Financial Results Conference Call

PALO ALTO, Calif. & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) (“Babylon” or the “Company”) will host a conference call on Thursday, May 12, 2022, at 8:00 AM Eastern Time to review the Company’s first quarter 2022 financial results. A press release announcing the first quarter results will be issued prior to the conference call on Thursday, May 12, 2022.

To participate in the Company’s live conference call and webcast, please dial 877-407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants, or +1 215-268-9868 for international participants. Alternatively, you can visit the “News & Events” section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a “Call me” link for instant telephone access to the event, which will be made active 15 minutes prior to the scheduled start time. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

About Babylon

Babylon is one of the world’s fastest growing digital healthcare companies whose mission is to make high-quality healthcare accessible and affordable for every person on Earth.

Babylon is re-engineering how people engage with their care at every step of the healthcare continuum. By flipping the model from reactive sick care to proactive healthcare through the devices people already own, it offers millions of people globally ongoing, always-on care. Babylon has already shown that in environments as diverse as the developed UK or developing Rwanda, urban New York or rural Missouri, for people of all ages, it is possible to achieve its mission by leveraging its highly scalable, digital-first platform combined with high quality, virtual clinical operations to provide integrated, personalized healthcare.

Founded in 2013, Babylon’s technology and clinical services is supporting a global patient network across 15 countries, and is capable of operating in 16 languages. And through a combination of its value-based care model, Babylon 360, and its work in primary care through NHS GP at Hand, Babylon managed over 440k lives globally from the start of 2022. In 2021 alone, Babylon helped a patient every 6 seconds, with approximately 5.2 million consultations and AI interactions. Importantly, this was achieved with a 93% user retention rate and 4 or 5 star ratings from more than 95% of our users.

Babylon is already working with governments, health providers, employers and insurers across the globe in order to provide them with a new infrastructure that any partner can use to deliver high-quality healthcare with lower costs and better outcomes. For more information, please visit www.babylonhealth.com.

Media

Adam Davison

[email protected]

Investors

[email protected]

KEYWORDS: Europe United States United Kingdom North America California

INDUSTRY KEYWORDS: Software Internet Managed Care General Health Health Data Management Technology Other Technology

MEDIA:

Logo
Logo

Kennedy Wilson to Announce First Quarter 2022 Earnings

Kennedy Wilson to Announce First Quarter 2022 Earnings

Company to hold conference call and webcast to discuss first quarter financial results

BEVERLY HILLS, Calif.–(BUSINESS WIRE)–
Global real estate investment company Kennedy Wilson (NYSE: KW) will release its first quarter 2022 financial results on Wednesday, May 4, 2022 after the market closes. The company will hold a live conference call and webcast to discuss results at 9:00 a.m. PT / 12:00 p.m. ET on Thursday, May 5, 2022.

The direct dial-in number for the conference call is (844) 340-4761 for U.S. callers and +1 (412) 717-9616 for international callers.

A replay of the call will be available for one week beginning one hour after the live call and can be accessed at (877) 344-7529 for U.S. callers and +1(412) 317-0088 for international callers. The passcode for the replay is 2523360.

The webcast will be available at: https://services.choruscall.com/mediaframe/webcast.html?webcastid=je7DjK2k.

A replay of the webcast will be available one hour after the original webcast on the Company’s investor relations web site for three months.

About Kennedy Wilson

Kennedy Wilson (NYSE:KW) is a leading global real estate investment company. We own, operate and invest in real estate through our balance sheet and through our investment management platform. We focus on multifamily and office properties located in the Western U.S., U.K., and Ireland. For further information on Kennedy Wilson, please visit: www.kennedywilson.com.

KW-IR

Investors

Daven Bhavsar, CFA

Vice President of Investor Relations

(310) 887-3431

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Professional Services Residential Building & Real Estate Commercial Building & Real Estate Finance Construction & Property REIT

MEDIA:

Logo
Logo

Amcor increases use of advance recycling materials leveraging ExxonMobil’s Exxtend™ technology

PR Newswire

New technology will result in more sustainable flexible polyethylene packaging


CHICAGO
, April 12, 2022 /PRNewswire/ — Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging solutions, today announced it is the first company to purchase certified circular polyethylene material using ExxonMobil’s Exxtend™ technology for advanced recycling. Amcor will leverage this new material across its global portfolio, providing customers in healthcare and food industries with more recycled content in a variety of solutions and applications.

Increasing the use of advance recycling materials, such as circular polymers, is one way Amcor is meeting its sustainability pledge to develop all of its packaging to be recyclable or reusable by 2025. The use of these materials will significantly add to the 113,000 metric tons of recycled material Amcor used in its packaging in fiscal year 2021. The technology behind advance recycling materials allows plastic waste to be converted into brand new products that are no different in quality and performance from ones made with virgin raw materials, providing customers peace of mind and the benefit of increasing the use of recycled content in their packaging. 

“Using advanced recycled materials is yet another step forward in Amcor meeting the challenges of our industry and offering our customers more sustainable packaging solutions,” said Amcor Chief Commercial Officer Peter Konieczny. “By leveraging ExxonMobil’s Exxtend technology across our global product portfolio, Amcor is providing a true differentiator for our customers and the environment.”

“We are proud to see our relationship with Amcor expand with our Exxtend technology to help address their sustainability goals, as well as those of their customers,” said David Hergenrether, Vice President, Polyethylene, ExxonMobil. “We look forward to working closely with Amcor to develop products that meet customer expectations for high-performance PE products, while helping to recycle plastic waste.”

Using its Exxtend technology, ExxonMobil offers certified circular polymers with the International Sustainability and Carbon Certification Plus (ISCC PLUS) certification, which is widely recognized as an effective standard for certifying the circularity of chemical products that result from advanced recycling operations via mass balance attribution.


About Amcor

Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures and services. The Company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. Around 46,000 Amcor people generate $13 billion in annual sales from operations that span about 225 locations in 40-plus countries.

About ExxonMobil

ExxonMobil, one of the largest publicly traded international energy and petrochemical companies, creates solutions that improve quality of life and meet society’s evolving needs. The corporation’s primary businesses – Upstream, Product Solutions and Low Carbon Solutions – provide society with products that enable modern life, including energy, chemicals, lubricants, and lower-emissions technologies. ExxonMobil holds an industry-leading portfolio of resources, and is one of the largest integrated fuels, lubricants and chemical companies in the world.  To learn more, visit exxonmobil.com, the Energy Factor and exxonmobilchemical.com/exxtend.

Cision View original content:https://www.prnewswire.com/news-releases/amcor-increases-use-of-advance-recycling-materials-leveraging-exxonmobils-exxtend-technology-301523520.html

SOURCE Amcor

Signature Bank Adds Fedwire Feature to Its Signet™ Digital Payments Platform, Allowing Instant Transfers Through Its Application Programming Interface

Signature Bank Adds Fedwire Feature to Its Signet™ Digital Payments Platform, Allowing Instant Transfers Through Its Application Programming Interface

New Payment Rail Takes Signet One Step Closer to Becoming a Fully Integrated Payments Platform

NEW YORK–(BUSINESS WIRE)–Signature Bank (Nasdaq: SBNY), a New York-based, full-service commercial bank, announced today the addition of a new feature allowing its clients to initiate real-time Fedwire transactions through its blockchain-based digital payments platform, Signet™, directly through its Application Programming Interface (API). The addition of this Fedwire feature enables Signet clients to execute both Signet blockchain and traditional Fedwire payments through one API, providing clients with greater flexibility in automating treasury management workflows via Signature Bank’s integrated payments service.

The Signet API connectivity enables clients to directly integrate Signet’s instantaneous payments within their systems and workflows to access full transactional capabilities. The API integration affords Signet clients the ability to increase their level of financial controls and operational efficiencies in the form of speed and security when integrating the Bank’s digital payments platform directly into their products and services. The API advancements have been revolutionary for Signet users, and Signet continues to attract an increasing number of clients, deposits and ecosystems.

“Our Signet API clients continue to demand fast, secure funds transfers and seek to streamline their payments technology stack across a range of digital payment rails as well as legacy payment options. Adding the Fedwire API feature to Signet’s real-time settlement network extends its payment reach, resulting in a complete U.S. dollar payments platform. We continue to closely listen to our clients and directly respond to meet their ever-changing, evolving needs for further enhancing their business operations. We believe this new API Fedwire feature will drive additional adoption and grow Signet volumes. Since our launch of Signet, the Bank has been at the forefront of financial technology, and we will continue to find ways to enhance the technology offerings we bring to our clients,” explained Joseph J. DePaolo, Co-Founder, President and Chief Executive Officer at Signature Bank.

FTX.US, a U.S.-regulated cryptocurrency exchange, is among those benefitting from Signet. FTX CEO and Founder Sam Bankman-Fried commented on the Bank’s new Fedwire transfer feature: “Partnering with Signature Bank, an established financial institution and fintech pioneer, will allow us to continue to grow our business by leveraging all the advantages and key aspects of Signet. The implementation of an API-enabled, blockchain-based digital payments platform to initiate blockchain transactions and Fedwire transactions via Signet is just the latest move toward revolutionizing the payments industry through the power of blockchain technology.”

About Signature Bank

Signature Bank (Nasdaq: SBNY), member FDIC, is a New York-based, full-service commercial bank with 38 private client offices throughout the metropolitan New York area, as well as those in Connecticut, California and North Carolina. Through its single-point-of-contact approach, the Bank’s private client banking teams primarily serve the needs of privately owned businesses, their owners and senior managers.

The Bank has two wholly owned subsidiaries: Signature Financial, LLC, provides equipment finance and leasing; and, Signature Securities Group Corporation, a licensed broker-dealer, investment adviser and member FINRA/SIPC, offers investment, brokerage, asset management and insurance products and services.

Since commencing operations in May 2001, Signature Bank reached $118.45 billion in assets as of December 31, 2021. With $106.13 billion in deposits at year-end 2021, Signature Bank placed 19th on S&P Global’s list of the largest banks in the U.S., based on deposits.

Signature Bank was the first FDIC-insured bank to launch a blockchain-based digital payments platform. Signet™ allows commercial clients to make real-time payments in U.S. dollars, 24/7/365 and was also the first solution to be approved for use by the NYS Department of Financial Services.

For more information, please visit https://www.signatureny.com.

This press release and oral statements made from time to time by our representatives contain forward-looking statementswithin the meaning of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on those statements because they are subject to numerous risks and uncertainties relating to our operations and business environment, all of which are difficult to predict and may be beyond our control. Forward-looking statements include information concerning our expectations regarding future results, interest rates and the interest rate environment, loan and deposit growth, loan performance, operations, new private client teams and other hires, new office openings, business strategy and the impact of the COVID-19 pandemic on each of the foregoing and on our business overall. Forward-looking statements often include words such as may,believe,expect,anticipate,intend, “potential,” “opportunity,” “could,” “project,” “seek,” “target,” “goal”, “should,” “will,” “would,” plan,estimate or other similar expressions. As you consider forward-looking statements, you should understand that these statements are not guarantees of performance or results. They involve risks, uncertainties and assumptions that could cause actual results to differ materially from those in the forward-looking statements and can change as a result of many possible events or factors, not all of which are known to us or in our control. These factors include but are not limited to: (i) prevailing economic conditions; (ii) changes in interest rates, loan demand, real estate values and competition, any of which can materially affect origination levels and gain on sale results in our business, as well as other aspects of our financial performance, including earnings on interest-bearing assets; (iii) the level of defaults, losses and prepayments on loans made by us, whether held in portfolio or sold in the whole loan secondary markets, which can materially affect charge-off levels and required credit loss reserve levels; (iv) changes in monetary and fiscal policies of the U.S. Government, including policies of the U.S. Treasury and the Board of Governors of the Federal Reserve System; (v) changes in the banking and other financial services regulatory environment, (vi) our ability to maintain the continuity, integrity, security and safety of our operations and (vii) competition for qualified personnel and desirable office locations. All of these factors are subject to additional uncertainty in the context of the COVID-19 pandemic, which is having an unprecedented impact on all aspects of our operations, the financial services industry and the economy as a whole. Additional risks are described in our quarterly and annual reports filed with the FDIC. Although we believe that these forward-looking statements are based on reasonable assumptions, beliefs and expectations, if a change occurs or our beliefs, assumptions and expectations were incorrect, our business, financial condition, liquidity or results of operations may vary materially from those expressed in our forward-looking statements. You should keep in mind that any forward-looking statements made by Signature Bank speak only as of the date on which they were made. New risks and uncertainties come up from time to time, and we cannot predict these events or how they may affect the Bank. Signature Bank has no duty to, and does not intend to, update or revise the forward-looking statements after the date on which they are made.

Investor Contact:

Brian Wyremski, Senior Vice President and Director of Investor Relations & Corporate Development

646-822-1479, [email protected]

Media Contact:

Susan Turkell Lewis, 646-822-1825, [email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

CME Group Announces New Regional Leadership Structure to Strengthen Focus on International Business Growth and Facilitate Enhanced Service to Clients Outside the United States

PR Newswire


CHICAGO, LONDON and SINGAPORE
, April 12, 2022 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced a new regional leadership structure to support its growing international business in Europe, Middle East and Africa (EMEA) and Asia Pacific.

The new structure is designed to enhance the company’s ability to provide local expertise and globally relevant products and services that meet the diverse risk management needs of its clients around the world. Reporting to Derek Sammann, Senior Managing Director, Global Head of Commodities, Options and International Markets and a member of the CME Group Management Team, the following executives have been appointed to new roles:

  • Michel Everaert, has been named Managing Director and Head of EMEA, a new position based in London. Everaert joined CME Group in 2011 and most recently served as the company’s Managing Director and Co-Head of Client Development & Sales (CD&S) for EMEA. He has 30 years of experience in derivatives markets including roles at IMEX Group, GFI Group, Logica, Reuters and Dow Jones.

  • Russell Beattie will join CME Group in May as Managing Director and Head of Asia Pacific. Based in Singapore, Beattie has over 25 years of experience in the listed and OTC derivatives markets and most recently served as Head of Asia Pacific Derivatives Indexes for MSCI. He also held APAC leadership roles for Bank of America Securities, Barclays, Deutsche Bank and HSBC. He replaces Chris Fix who retired in March 2022.

Additionally, Serge Marston has been appointed Managing Director and Head of CD&S for EMEA, responsible for leading CME Group’s sales efforts in the region across both listed derivatives and cash markets. Marston will be based in London and will report to David Hartney, Global Head of CD&S. Marston joined CME Group in 2018 following the company’s acquisition of NEX Group and most recently served as Co-Head of CD&S for EMEA. Marston previously worked at Deutsche Bank for nearly 20 years where he held a variety of roles including Global Head of eCommerce Sales.

William Knottenbelt, who currently serves as Senior Managing Director, Head of International, will retire at yearend. 

“After record volume growth in EMEA and Asia Pacific for each of the past 10 years, approximately 30% of our revenue is now generated from non-U.S. markets,” said Sammann. “Building on that momentum, the organizational changes announced today further elevate both the significance and opportunities that these regions represent to our overall business and reflect the many achievements of our talented regional team members. To that end, I want to thank William for his contributions in getting us to this point in the continued evolution of our international business. 

“I’m now pleased to appoint Michel Everaert, who is a long-standing CME Group employee, to head our EMEA region and name Russell Beattie to lead our business in Asia Pacific. Our new structure will enhance our ability to provide local expertise and globally relevant products and services to meet the diverse risk management needs of our clients around the world.”

In Q1 2022, outside the United States, CME Group reached average daily volume (ADV) of 7.3 million contracts, up 18% year on year. The increase was driven by 17% growth in EMEA (5.1 million contracts ADV) and 22% growth in Asia Pacific (1.9 million contracts ADV), compared to the same period last year.

In 2021, CME Group saw a record ADV of 5.5 million contracts from outside of the U.S., representing 28% of total volume. EMEA volume reached a record 4 million ADV, up 3%; Asia Pacific reached a record 1.3 million in ADV, an increase of 5%; and Latin America volume was up 5% over the same period.

About CME Group

As the world’s leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest ratesequity indexesforeign exchangeenergyagricultural products and metals. The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor’s Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc.  All other trademarks are the property of their respective owners. 

CME-G

Cision View original content:https://www.prnewswire.com/news-releases/cme-group-announces-new-regional-leadership-structure-to-strengthen-focus-on-international-business-growth-and-facilitate-enhanced-service-to-clients-outside-the-united-states-301523429.html

SOURCE CME Group

Arqit Joins UK MOD’s Connectivity of Disparate Remote Autonomous Systems Framework

Arqit has signed a contract with MOD to join its Framework for Connectivity of Disparate Remote Autonomous Systems (the “MDIS Project”)

LONDON, April 12, 2022 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (“Arqit”), a global leader in quantum encryption technology, is pleased to announce that it has been selected by the UK Ministry of Defence to join its Multi-Domain Integrated Systems (MDIS) Project.

The MOD has a developing requirement for the creation or adoption of a set of common standards and/or architecture for interfaces, data transfer and data management that can be used both for upgrades to legacy systems and future procurement to enable swift and simple interoperation of systems. The work will involve demonstrations of multi-domain integrated systems which may include autonomous and swarming technologies.

In particular Arqit will focus on areas of Data Management and Fusion, and Communications Bearers, Network Architecture and Services.

Arqit Founder, Chairman and CEO, David Williams, added
: “We are delighted to sign this contract with the MOD. Given recent progress announced with other Five-Eyes partners, interoperability is a significant advantage for us and crucial to the success of any MDI (known as JADC2 in USA) initiative to support future joint operations.   Military Data systems need to be automated, interconnected, and interoperable across multiple domains globally. They require machine-to-machine as well as human-to-human and human-to-machine interfaces of unprecedented scale and connectivity and need a modern security architecture to match.”

MDIS Project Manager, Future Capabilities Group, MOD said
: “An MDIS capability relies on the collection, aggregation, and dissemination of a large amount of data. MDIS will be Secure by design: Security shall be embedded in thinking throughout all architectures, designs and implementations and shall follow a set of security principles such as zero-trust, encryption, least privilege and need-to-know by default. This ensures that any connectivity capability is secure, without requiring later rework to consider security.”

About Arqit

Arqit supplies a unique quantum encryption Platform-as-a-Service which makes the communications links of any networked device secure against current and future forms of attack – even from a quantum computer. Arqit’s product, QuantumCloud™, enables any device to download a lightweight software agent, which can create encryption keys in partnership with any other device. The keys are computationally secure, optionally one-time use and zero trust. QuantumCloud™ can create limitless volumes of keys in limitless group sizes and can regulate the secure entrance and exit of a device in a group. The addressable market for QuantumCloud™ is every connected device. 

Media relations enquiries:

Arqit:
[email protected]

FTI Consulting:
[email protected]

Investor relations enquiries:

Arqit:
[email protected]

Gateway:

[email protected]

Caution About Forward-Looking Statements

This communication includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These forward-looking statements are based on Arqit’s expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond Arqit’s control. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for Arqit to predict these events or how they may affect it. Except as required by law, Arqit does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date this communication is issued. In light of these risks and uncertainties, investors should keep in mind that results, events or developments discussed in any forward-looking statement made in this communication may not occur. Uncertainties and risk factors that could affect Arqit’s future performance and cause results to differ from the forward-looking statements in this release include, but are not limited to: (i) risks that the business combination disrupts Arqit’s current plans and operations, (ii) the outcome of any legal proceedings that may be instituted against the Arqit related to the business combination, (iii) the ability to maintain the listing of Arqit’s securities on a national securities exchange, (iv) changes in the competitive and regulated industries in which Arqit operates, variations in operating performance across competitors, changes in laws and regulations affecting Arqit’s business and changes in the combined capital structure, (v) the ability to implement business plans, forecasts, and other expectations after the completion of the business combination, and identify and realize additional opportunities, (vi) the potential inability of Arqit to convert its pipeline or orders in backlog into revenue, (vii) the potential inability of Arqit to successfully deliver its operational technology which is still in development, (viii) the risk of interruption or failure of Arqit’s information technology and communications system, (ix) the enforceability of Arqit’s intellectual property, and (x) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Arqit’s annual report on Form 20-F, filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 16, 2021 and in subsequent filings with the SEC. While the list of factors discussed above and the list of factors presented in the final prospectus are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements.